Moisturizers for patients with atopic dermatitis

Asian Pacific Journal of Allergy and Immunology

Volumn 31, Issue 2, 2013, Pages 91-98

  Varothai, Supenya ^a   Nitayavardhana, Sunatra ^a   Kulthanan, Kanokvalai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Atopic dermatitis; Atopic xerosis; Emollients; Moisturizers; Moisturizers with anti inflammatory properties

Indexed keywords

2 PYRROLIDONE DERIVATIVE; ALOE VERA EXTRACT; CERAMIDE; CHAMOMILE; COAL TAR; COCONUT OIL; CORTICOSTEROID; FILAGGRIN; FLUTICASONE; GLYCEROL; GRAPE SEED EXTRACT; HYPERFORIN; LANOLIN; LAURIC ACID; LICOCHALCONE A; LINOLEIC ACID; LINOLENIC ACID; NICOTINAMIDE; OLEIC ACID; PALMIDROL; PARAFFIN; PETROLATUM; PLACEBO; PROPOLIS; PROPYLENE GLYCOL; PROTEINASE; SKIN CREAM; SORBITOL; STEARIC ACID; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ATOPIC DERMATITIS; COMPARATIVE STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN REGULATION; DRY SKIN; HUMAN; MULTICENTER STUDY (TOPIC); NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN WATER LOSS; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; TIGHT JUNCTION; XEROSIS;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; COSMETICS; DERMATITIS, ATOPIC; HUMANS; MALE; SKIN;

EID: 84881490120     PISSN: 0125877X     EISSN: 22288694     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Danby S, Cork MJ. A New understanding of atopic dermatitis: the role of epidermal barrier dysfunction and subclinical inflammation. J Clin Dermatol. 2010;1:33-46.
2. Saijic D, Asiniwasis R, Skotnicki-Grant S. A look at epidermal barrier function in atopic dermatitis: Physiologic lipid replacement and the role of ceramide. Skin Therapy Lett. 2012;7:6-9.
3. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Science. 2010;58:1-7.
4. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep. 2009;9:265-72
5. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML. et al. The objective severity assessment of atopic dermatitits score:and objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol. 2003;139:1417-22.
6. Rodriguez E, Baurecht H, Herberich E, Wagenpfeil S, Brown SJ, Cordell HJ. et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma; robust risk factors in atopic diseases. J Allergy Clin Immunol. 2009;123:1361-70
7. Elias PM, Wakefield JS. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol. 2011;41:282-95.
8. Rawlings AV, Harind CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17:43-8.
9. Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M. et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892-908.
10. Wolf R, Wolf D. Abnormal epidermal barrier in the pathogenesis of atopic dermatitis. Clinics in Dermatology. 2012;30:329-34.
11. De Benedetto A, Kubo A, Beck LA. Skin barrier disruption: A requirement for allergen. J Invest Dermatol 2012; 132: 949-963.
12. McGirt LY, Beck LA. Innate immune defects in atopic dermatitis. J Allergy Clin Immunol. 2006;118:202-8.
13. Ong PY, Leung DY. The infectious aspects of atopic dermatitis. Immunol Allergy Clin North Am. 2010;30:309-21.
14. Elias PM. The skin barrier as an innate immune element. Semin Immunopathol. 2007;29:3-14
15. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 132:949-63.
16. Wollenberg A, Frank R, Kroth J, Ruzicka T. Proactive therapy of atopic eczema-an evidence-base concept with a behavioral background. JDDG 2009;7:117-21.
17. Tagami H, Kobayashi H, O'Goshi K, Kikuchi K. Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products. J Cosmet Dermatol. 2006;5:140-9.
18. Anderson C, Dinulos JG. Are the new moisturizers more effective? Curr Opin Pediatr. 2009;21:486-90.
19. Darsow U, Wollenberg A, Simon D, Taieb A, Warfel T, Oranji A. et al. ETFAD/EADV eczema task force 2009 posititon paper on diagnosis and treatment of atopic dermatitis. JEADV. 2010;24:317-28.
20. Seaki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I. et al. Guideline for management of atopic dermatitis. J Dermatol. 2009;36:563-77.
21. Grimalt R, Mengeaud V, Cambazard F, Study Investigators' Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology. 2007;214:61-7.
22. Draelos ZD. Therapeutic moisturizers. Dermatol Clin. 2000;18:597-607
23. Buraczewska I, Berne B, Linberg M, Torma H, Londen M. Change in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. BJD. 2007;156:492-8.
24. Loden M. Effect of moisturizers on epidermal barrier function. Clin Dermatol. 2012; 30:286-96.
25. Sawai H, Domae N, Okazaki T. Current status and perspectives in ceramide-targeting molecular medicine. Curr Pharm Des. 2005;11:2479-87.
26. Ishikawa J, Shimotoyodome Y, Chen S, Ohkubo K, Takagi Y, Fujimura T, et al. Eucalyptus increases ceramide levels in keratinocytes and improves stratum corneum function. Int J Cosmet Sci. 2012;34:17-22.
27. Simpson E, Böling A, Bielfeldt S, Bosc C, Kerrouche N. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat. 2013;24:122-5.
28. Anderson PC, Dinulos JG. Are the new moisturizers more effective?. Curr Opin Pediatr. 2009;21:486-90.
29. Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol. 2009;8:1106-11.
30. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatol Ther. 2004;17:49-56
31. Lynde CW. Moisturizers: What they are and how they work. Skin therapy Lett. 2001;6:3-5.
32. Patzelt-Wenezler R, Ponce-Poschl E. Proof of efficacy of Kamillosan cream in atopic eczema. Eur J Med Res. 2000;5:171-5.
33. Dal'Belo SE, Gaspar LR, Maia Compos PM. Moisturing effect of cosmetic formulations containing Aloe vera extract in different concentrations assessed by skin bioengineering techniques. Skin Res Technol. 2006:241-6.
34. Panahi Y, Davoudi SM, Sahebkar A, Beiraghdar F, Dadjo Y, Feizi I, et al. Cutan Ocul Toxicol. 2012;31:95-103.
35. Schempp CM, Hezel S, Simon JC. Topical treatment of atopic dermatitis with hypericum cream: a randomized, placebocontrolled, double blind half-side comparison study. Hautarz. 2003;54:248-53.
36. Zakaria ZA, Somchit MN, Mat Jais AM, Teh LK, Salleh MZ, Long K. Anti-inflammatory, analgesic and antipyrectic activities of vergin coconut oil. Med Princ Pract. 2011;20:231-6.
37. Di Vincenzo D, Maranz S, Serraiocco A, Vito R, Wiesman Z, Bianchi G. Regional variation in shea butter lipid and triterpene composition in four African countries. J Agric Food Chem. 2005;53:7473-9.
38. Akihisa T, Kojima N, Kikuchi T, Yasukawa K, Tokuda H, T Masters E et al. Anti-inflammatory and chemopreventive effects of triterpene cinnamates and acetates from shea fat. J Oleo Sci. 2010;59:273-80.
39. Abramovits W, Boguniewicz M. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol. 2006;5:236-44.
40. Patrizi A, Capitanio B, Neri I, Giacomini F, Sinagra JL, Raone B.A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients. Pediatr Allergy Immunol. 2008;19:619-25.
41. Veraldi S, De Micheli P, Schianchi R, Lunardon L. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical nonsteroidal agent. J Drugs Dermatol. 2009;8:537-9.
42. Kolbe L, Immeyer J, Batzer J, Wensorra U, tom Dieck K, Mundt C. et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res. 2006;298:23-30.
43. Wananukul S, Chatproedprai S, Charutragulchai W. Randomized, double-blind, split-side comparison study of moisturizer containing licochalcone vs. 1% hydrocortisone in the treatment of infantile seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2012;26:894-7.
44. Udompataikul M, Srisatwaja W. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study. J Eur Acad Dermatol Venereol. 2011;25:660-5.
45. Eric S, Nathan T, Ronald R, Norman P, Luz E, Lori J et al. Safety and Tolerability of a body wash and moisturizer When applied to Infants and Toddlers with a History of Atopic dermatitis: Results from an Open-label Study. Pediatric dermatology 2012;29:590-597.
46. Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135-41.
47. Mohammed D, Crowther JM, Matts PJ, Hadgraft J, Lane ME. Influence of niacinamide containing formulations on the molecular and biophysical properties of the stratum corneum. Int J Pharm. 2013;441:192-201.
48. Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T, Mizoguchi M. Moisturizing effects of topical nicotinamide on atopic dry skin. Int J Dermatol. 2005;44:197-202.
49. Christman JC, Fix DK, Lucus SC, Watson D, Desmier E, Wilkerson RJ, Fixler C. Two randomized, controlled, comparative studies of the stratum corneum integrity benefits of two cosmetic niacinamide/glycerin body moisturizers vs. conventional body moisturizers. J Drugs Dermatol. 2012;11:22-9.
50. Eberlein B, Eicke C, Reinhardt HW, Ring J. Adjuvant treatment of atopic eczema: assessment of an emollient containing Npalmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol. 2008;22:73-82.
51. van den Bogaard EH, Bergboer JG, Vonk-Bergers M, van Vlijmen-Willems IM, Hato SV, van der Valk PG, et al. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest. 2013;123:917-27.